Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
16.17
-1.89 (-10.47%)
Nov 20, 2024, 4:00 PM EST - Market closed
ARCT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Revenue | 160.4 | 166.8 | 206 | 12.36 | 9.54 | 20.79 | Upgrade
|
Revenue Growth (YoY) | -45.85% | -19.03% | 1566.79% | 29.56% | -54.12% | 31.97% | Upgrade
|
Cost of Revenue | 188 | 192.13 | 147.75 | 173.76 | 55.95 | 32.44 | Upgrade
|
Gross Profit | -27.6 | -25.33 | 58.25 | -161.4 | -46.41 | -11.65 | Upgrade
|
Selling, General & Admin | 52.95 | 52.87 | 46.07 | 41.45 | 25.12 | 13.86 | Upgrade
|
Operating Expenses | 52.95 | 52.87 | 46.07 | 41.45 | 25.12 | 13.86 | Upgrade
|
Operating Income | -80.55 | -78.21 | 12.18 | -202.85 | -71.52 | -25.51 | Upgrade
|
Interest Expense | -0 | -0.77 | -3 | - | -0.83 | -0.85 | Upgrade
|
Interest & Investment Income | 18.87 | 17.36 | 2.58 | - | 0.47 | 0.41 | Upgrade
|
Earnings From Equity Investments | - | - | -0.52 | 0.52 | -0.26 | -0.03 | Upgrade
|
Currency Exchange Gain (Loss) | -0.7 | -0.23 | -0.6 | 0.58 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -0 | -0 | - | -1.92 | - | - | Upgrade
|
EBT Excluding Unusual Items | -62.38 | -61.84 | 10.64 | -203.67 | -72.15 | -25.99 | Upgrade
|
Other Unusual Items | - | 33.95 | - | - | - | - | Upgrade
|
Pretax Income | -62.38 | -27.89 | 10.64 | -203.67 | -72.15 | -25.99 | Upgrade
|
Income Tax Expense | 0.26 | 1.84 | 1.3 | - | - | - | Upgrade
|
Net Income | -62.64 | -29.73 | 9.35 | -203.67 | -72.15 | -25.99 | Upgrade
|
Net Income to Common | -62.64 | -29.73 | 9.35 | -203.67 | -72.15 | -25.99 | Upgrade
|
Shares Outstanding (Basic) | 27 | 27 | 26 | 26 | 20 | 12 | Upgrade
|
Shares Outstanding (Diluted) | 27 | 27 | 27 | 26 | 20 | 12 | Upgrade
|
Shares Change (YoY) | -0.95% | -1.72% | 2.95% | 29.61% | 68.24% | 19.86% | Upgrade
|
EPS (Basic) | -2.33 | -1.12 | 0.35 | -7.74 | -3.55 | -2.15 | Upgrade
|
EPS (Diluted) | -2.33 | -1.12 | 0.35 | -7.74 | -3.55 | -2.15 | Upgrade
|
Free Cash Flow | -61.62 | -21 | 24.27 | -138.45 | -44.6 | -7.26 | Upgrade
|
Free Cash Flow Per Share | -2.29 | -0.79 | 0.90 | -5.26 | -2.20 | -0.60 | Upgrade
|
Gross Margin | -17.21% | -15.19% | 28.28% | - | - | -56.04% | Upgrade
|
Operating Margin | -50.22% | -46.89% | 5.91% | -1641.33% | -749.81% | -122.72% | Upgrade
|
Profit Margin | -39.05% | -17.82% | 4.54% | -1647.98% | -756.35% | -125.02% | Upgrade
|
Free Cash Flow Margin | -38.41% | -12.59% | 11.78% | -1120.23% | -467.59% | -34.94% | Upgrade
|
EBITDA | -77.01 | -75.25 | 13.7 | -201.66 | -70.64 | -24.83 | Upgrade
|
EBITDA Margin | -48.01% | -45.11% | 6.65% | - | - | -119.43% | Upgrade
|
D&A For EBITDA | 3.54 | 2.96 | 1.53 | 1.19 | 0.88 | 0.68 | Upgrade
|
EBIT | -80.55 | -78.21 | 12.18 | -202.85 | -71.52 | -25.51 | Upgrade
|
EBIT Margin | -50.22% | -46.89% | 5.91% | - | - | -122.72% | Upgrade
|
Effective Tax Rate | - | - | 12.17% | - | - | - | Upgrade
|
Revenue as Reported | 160.4 | 166.8 | 206 | 12.36 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.